Sign in
Knowstox

Fundamentals snapshot

Retractable Technologies, Inc.

RVP · ASE · Healthcare · Medical Instruments & Supplies

Current price

$0.56

52-week range

$0.56 - $0.87

Market cap

$16.76M

One-glance verdict

Undervalued

$2.23 our estimate vs market $0.56

Balance sheet

Healthy

-162.33x Concerning

Net cash $38.90M. Interest coverage shows how many times profit covers the interest bill.

What this company does

Retractable Technologies, Inc.

Retractable Technologies, Inc. makes safety needles and syringes for doctors and hospitals, like the VanishPoint insulin syringe that automatically retracts to prevent accidental needle sticks. Their main income comes from selling these safety medical devices to healthcare providers in the US and other countries, which is important because it helps reduce injuries from used needles.

Price history

How the share price has moved

—
Loading price history…

Earnings history

Last 8 quarters — what happened

Click any quarter to read the call summary and what the numbers say.

Free cash flow by quarter (oldest to newest)
FY2024 Q3 $-6.52M FY2024 Q4 $-1.40M FY2025 Q1 $-1.56M FY2025 Q2 $-4.07M FY2025 Q3 $-1.35M FY2026 Q1 $-1.37M FY2026 Q2 $-1.76M
Revenue $7.20M
Net income $2.83M
Diluted EPS 0.09
Operating cash flow $-1.73M
Free cash flow $-1.76M
Revenue $7.18M
Net income $-4.23M
Diluted EPS -0.14
Operating cash flow $-1.37M
Free cash flow $-1.37M
Revenue $9.44M
Net income $-2.35M
Diluted EPS -0.09
Operating cash flow $-596.54K
Free cash flow —
Revenue $10.09M
Net income $371.05K
Diluted EPS 0.01
Operating cash flow $-1.26M
Free cash flow $-1.35M
Revenue $10.45M
Net income $-87.47K
Diluted EPS 0.00
Operating cash flow $-3.73M
Free cash flow $-4.07M
Revenue $8.30M
Net income $-10.50M
Diluted EPS -0.35
Operating cash flow $-1.48M
Free cash flow $-1.56M
Revenue $9.07M
Net income $3.77M
Diluted EPS 0.14
Operating cash flow $-1.10M
Free cash flow $-1.40M
Revenue $10.35M
Net income $-1.92M
Diluted EPS -0.07
Operating cash flow $-5.73M
Free cash flow $-6.52M

Is it cheap or expensive?

Fair value $2.23 vs current price $0.56

Our most-likely fair value is $2.23 a share — about 298.3% above today's price of $0.56, so the stock currently looks cheap (undervalued).

undervalued

We estimate the cash this business should generate over the next 10 years and beyond, then convert it to today's money for a fair value per share, in its trading currency. Cautious, middle and optimistic growth cases give a range. Not for banks/insurers.

Base

Growth 2.5% · Discount 9.5% · Terminal 2.5%

$2.23

Bear

Growth 2.5% · Discount 9.5% · Terminal 2.5%

$2.23

Bull

Growth 5.5% · Discount 9.5% · Terminal 2.5%

$2.40

Is it drowning in debt?

Healthy

Net cash $38.9M - more cash than debt. Interest coverage -162.3x.

Net debt $-38.90M
Interest coverage -162.33x

Retractable Technologies, Inc. is healthier than 0 of 1 peers on balance-sheet leverage.

Healthy
Worse cushion Baseline Better cushion
RVP BASELINE Retractable Technologies, Inc.

Total debt $973.89K Interest coverage -162.33x This is the baseline the peer rows are being compared against.

-162.33x

What you should know

The case for and against RVP

1 Reward 2 Risks

Rewards

  • Free cash flow was positive in 2/10 years.

Risks

  • Operating margin compressed from 3.1% to -71.5% over 3 years.
  • Return on equity was -4.5% last year — the company lost money on shareholders' equity.

The numbers

All the key metrics, grouped by purpose

Tap any ? icon to learn what it means.

Valuation

How expensive the stock looks

P/E (TTM)
—
Forward P/E
—
P/B
0.23x
P/S
0.49x
EV/EBITDA
1.57x
PEG ratio
—

Profitability

How much profit each dollar creates

Gross margin
-1.5%
Operating margin
-71.5%
Net margin
-9.9%
ROE
-4.5%
ROA
-9.4%

Health

Liquidity and balance-sheet strength

Debt / equity
0.01x
Current ratio
4.93x
Quick ratio
3.68x
Total debt
$973.89K
Total cash
$39.87M

Growth

How the business has been compounding

Revenue TTM
$33.90M
Revenue 5Y CAGR
-32.9%
EPS TTM
-0.12
EPS 5Y CAGR
—

Cash flow

How much cash the business throws off

Operating CF TTM
$-4.96M
Free CF TTM
$-13.00M
FCF margin
-38.3%

Dividend

Shareholder payout

Yield
0.0%
Payout ratio
0.0%
Last ex-div date
—